ReportsnReports - Warner-Chilcott Plc: PharmaVitae Report

11-Dec-2011 | News-Press Release

This analysis Warner-Chilcott Plc: PharmaVitae Report examines the historical and forecast performance for Warner-Chilcott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits
• Gain insight into Warner-Chilcott’s strategic outlook across the next 6 years.
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.

Browse All: Pharmaceuticals Market Research

Table Of Contents
ABOUT THIS REPORT
PharmaVitae Explorer database
Chapter structure
Strategic insight
Company introduction
Sales analysis
Financial analysis
Product analysis
Data sourcing
Analyst consensus

EXECUTIVE SUMMARY
Key findings
Warner Chilcott prescription pharma sales outlook
Warner Chilcott financial outlook
SWOT analysis
Weaknesses
Opportunities
Threats

STRATEGIC INSIGHT
Proctor & Gamble acquisition will shape performance through to 2016
Portfolio has undergone substantial change
Impact of expiries increased by narrower product focus
Patent expiries non-negotiable – pre-erosion cash flow critical to future expansion
P&G acquisition will drive superior operating performance…
and provide platform for further diversification and strategic evolution

COMPANY INTRODUCTION
Background
M&A history

SALES ANALYSIS
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2004–16
Product analysis
Product analysis, 2010–16
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Explanation of launch/core/expiry analysis
Launch analysis, 2010–16
Core analysis, 2010–16
Expiry analysis, 2010–16
Launch/core/expiry configuration, 2010–16
Molecule type analysis
Externalization analysis

FINANCIAL ANALYSIS
Key findings
Operating costs and profit analysis
Operating costs and profit analysis, 2004–10
Operating cost ratio and profit margin analysis, 2004–10
Operating cost ratio and profit margin analysis, 2010–16
Operating costs and profit analysis, 2010–16

PRODUCT ANALYSIS
Overview
Asacol
Actonel
Enablex
Loestrin
Estrace
Doryx
APPENDIX
References
Exchange rates

About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com

http://www.reportsnreports.com

Blog: http://www.reportsnreportsblog.com/

 

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Message
Login to Submit Email

Author Info

Tag Cloud

Categories

More Releases

Comments

Add a Comment

    \n\